---
title: "Beijing Tide Pharmaceutical: Loxoprofen Sodium Gel Patch approved for market launch, achieving a full pipeline layout in the pain relief field"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/227479045.md"
description: "SINO BIOPHARM's subsidiary Beijing Tide Pharmaceutical announced that its developed Loxoprofen Sodium Gel Patch has recently been approved for marketing by the National Medical Products Administration of China, indicated for inflammation and pain relief for osteoarthritis, muscle pain, and swelling pain caused by trauma"
datetime: "2025-02-07T06:26:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/227479045.md)
  - [en](https://longbridge.com/en/news/227479045.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/227479045.md)
---

# Beijing Tide Pharmaceutical: Loxoprofen Sodium Gel Patch approved for market launch, achieving a full pipeline layout in the pain relief field

SINO BIOPHARM's subsidiary Beijing Tide Pharmaceutical announced that its developed Loxoprofen Sodium Gel Patch has recently been approved for marketing by the National Medical Products Administration of China, indicated for the treatment of osteoarthritis, muscle pain, and inflammation and pain relief caused by trauma

### Related Stocks

- [01177.HK](https://longbridge.com/en/quote/01177.HK.md)

## Related News & Research

- [Sino Biopharm Showcases Promising Obesity Antibody Data and Expands Weight-Loss Pipeline](https://longbridge.com/en/news/286328735.md)
- [Sino Biopharm Advances First-in-Class CCR8 Antibody Into Phase III Gastric Cancer Trial](https://longbridge.com/en/news/285458913.md)
- [15 individuals indicted in alleged health-care fraud scheme in Minnesota](https://longbridge.com/en/news/287276323.md)
- [The next evolution of American healthcare is here](https://longbridge.com/en/news/287386441.md)
- [Q&A: How 3PLs are navigating the latest pharma trends](https://longbridge.com/en/news/287389735.md)